First Earnings as a Listed Spirit: IGL Spirits Bows in Premiumisation Moment
Six weeks into public life after October demerger from India Glycols, IGL Spirits reports Q2 FY27 earnings on November 12. The spirits maker faces a backdrop of modest 2% market growth but standout premiumization gains—vodka volume jumped 49% and premium whisky climbed 6% in the quarter—and a biofuels offset of material revenue. The Street has little fresh coverage; pre-listing analysts valued the spirits unit at 15x FY29E EBITDA. Watch for volume momentum, margin pressure from commodity costs, and the company's dividend policy as signals of management intent post-listing.
What to Expect
~₹340–360 Cr
FY26 Q2 baseline ~₹330 Cr; 3–9% growth on price/mix amid 5–8% volume lift from premiumisation
~₹360–380 Cr
Material but volatile; H1 FY26 run-rate ~₹730 Cr for full half. Commodity-linked, margin pressure expected
~35–38%
Premium mix should help, but input cost inflation is a headwind
~22–25%
No change to guidance; demerger allows separate tax planning
A strong quarter would show spirits volume growth of 8%+ with price-mix contribution from premiumisation (whisky premium up 6% YoY, vodka up 49%, rum up 20% in recent quarters). Biofuels should hold margin above 20% even with commodity pressure. A weak print would see spirits volume flat or negative YoY, blended EBITDA margin below 30%, and mass-market category erosion outpacing premium gains. The bar is modest on debut, but Street will scrutinise volume momentum and biofuel resilience.
On Track?
IGL Spirits is only six weeks into public markets post-demerger (effective 1 September 2026), so prior guidance is sparse. Pre-listing, India Glycols' Investor Day (September 2026) outlined the spirits unit at 15x EV/EBITDA on FY29E EBITDA of ₹701 Cr, implying an EBITDA run-rate of ~₹280 Cr for Q2 would track on plan. Biofuels was not explicitly modelled by listed analysts pre-demerger. The key indicator will be whether volume growth (target: mid-single-digit %) keeps pace with premiumisation trends (category-wide 6–20% for premium), and whether margins resist commodity headwinds. Management commentary on FY27 guidance and dividend policy will be closely watched.
What the Street Says
Since Last Quarter
Listing (4 Nov 2026): IGL Spirits Listed on BSE and NSE after three-way demerger of India Glycols (also spun off Ennature Bio Pharma). Spirits shareholders received 1:1 allotment. Stock started trading and gapped up sharply on debut, reflecting pent-up interest in a pure-play spirits/biofuels play. Trading Window (4–13 Nov 2026): Window closed for insiders 48 hours post-result (closed Nov 4, re-opens Nov 15 post-announcement). No insider pledges or board moves reported. Business fundamentals unchanged—spirits (₹1,331 Cr FY26 revenue, 30M cases) and biofuels (₹1,470 Cr FY26 revenue) remain the two revenue pillars. Routine demerger housekeeping only; no material operational or governance red flags.
1 · Volume & Mix in Spirits
Did Q2 spirits volumes grow mid-single digits on premiumisation (whisky/vodka/rum premium tiers)? Watch the split between premium (+6–20% YoY) and mass-market (flat to negative). If mass-market weakness drives blended volume to flat or negative, red flag on market share vs. peers (Radico up 34% revenue Q2, United Spirits premium-led). Management guidance on FY27 volume target is critical.
2 · Biofuel Earnings & Sustainability
Biofuels contributed ₹1,470 Cr revenue in FY26 (~₹360 Cr Q2 run-rate). Is Q2 EBITDA margin above 20% despite commodity pressure (crude oil, ethanol feedstock costs)? Any commentary on FY27 volume/price trajectory? Biofuels is ~50% of earnings; volatility here will drive equity valuations as much as spirits.
3 · Capital Allocation & Dividend Policy
First call as a listed standalone company. Will management signal dividend, buyback, or capex for distillery/biofuel capex? Demerger freed up capital; Street will calibrate whether the company is growth-oriented or cash-generative. Signal here will set long-term valuation multiple for spirits (often 15–20x EBITDA) vs. commodity (8–12x).
IGL Spirits reports Q2 FY27 earnings on 12 November as a newly listed entity born from demerger. The backdrop is a spirits market growing only 2% YoY but seeing sharp premiumisation (vodka +49%, premium whisky +6%), and a biofuels segment that bridges a ₹1,470 Cr revenue floor but adds commodity volatility. Expect spirits revenue around ₹340–360 Cr with volume growth in the 5–8% range, biofuel earnings ~₹360–380 Cr. The Street has sparse coverage; pre-listing Arihant assigned 15x FY29E EBITDA (₹701 Cr), which implied ₹280 Cr quarterly EBITDA as a check. Watch for volume momentum (the true tell of premiumisation vs. market share loss), biofuel margin resilience, and the company's debut guidance on FY27 and capital allocation. Thin liquidity in the first six weeks post-listing means the print and call will set long-term valuation anchors.
IGL Spirits' maiden standalone quarter: PAT +6% YoY to ₹61 Cr as margin dips to 5.4%
PAT +6.32% YoY · revenue +10.32% · margins compressing
₹2,295.41 Cr
+10.32% YoY
₹61.2 Cr
+6.32% YoY
2.67%
₹9.13
IGL Spirits Limited's standalone Q2 FY27 (quarter ended September 30, 2026) revenue rose 10.3% YoY to ₹2,295.4 Cr, while profit after tax grew a slower 6.3% YoY to ₹61.2 Cr — profit growth trailing topline growth. EBITDA margin compressed to 5.4% from 6.0% a year earlier, and net profit margin eased to 2.67% from 2.77%, as cost of materials consumed and depreciation (up to ₹26.8 Cr from ₹24.3 Cr on the back of ₹54 Cr of H1 capex) rose faster than revenue; a partial offset came from finance costs falling to ₹15.1 Cr from ₹23.2 Cr YoY as the company paid down borrowings (net repayment of ₹88.4 Cr in H1 financing activities, taking total borrowings to ₹714.1 Cr from ₹802.5 Cr at March 31, 2026). Sequentially, revenue fell 9.7% QoQ to ₹2,295.4 Cr from ₹2,541.9 Cr, led by the Potable Spirits segment (down 13.5% QoQ to ₹1,919.1 Cr) — a seasonal pattern typical for the alcobev category rather than a demand issue — even as PAT still rose 2.7% QoQ on the margin recovery; this QoQ dip should not be read as weakness given YoY growth holds.
Q2 FY-2027 vs prior quarters
No year-ago quarter on record — YoY cells may be blank.
This is the company's first quarterly result as a standalone, separately listed entity: IGL Spirits was carved out of India Glycols Limited's spirits-and-biofuel undertaking via an NCLT-approved demerger (order dated July 17, 2026, appointed date April 1, 2026) and began trading on the BSE and NSE on November 4, 2026. The quarter's other corporate developments — adoption of new Articles of Association and designation of five senior management personnel, both on November 12, 2026 — are standard post-listing/post-demerger housekeeping and not operationally material to this print. There is no consolidated statement since the company has no subsidiary or associate (Note 4 of the filing); standalone is therefore the only and primary basis.
As a newly listed entity reporting its maiden result, there is no prior management guidance, concall commentary, or street consensus on record — a web search for analyst previews or consensus estimates on IGL Spirits specifically returned no coverage, so vsStreet and vsGuidance are both marked unknown rather than inferred. No management press release accompanied this filing beyond the standard board-outcome letter, so there is no company framing of the quarter to reconcile against the numbers.
W1
Whether EBITDA margin recovers from the 56bps YoY compression (5.4% vs 6.0%) in Q3 FY27, the festive-season quarter for the spirits category
W2
Potable Spirits segment PBIT trajectory (₹72.3 Cr this quarter vs ₹75.0 Cr YoY) as the post-demerger standalone cost structure beds in
W3
Pace of deleveraging — total borrowings fell to ₹714.1 Cr (from ₹802.5 Cr at FY26-end) after ₹88.4 Cr net repayment in H1; watch for continuation